Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study
BJS Open2020Vol. 4(2), pp. 284–292
Citations Over TimeTop 10% of 2020 papers
Sissel Ravn, Uffe Heide‐Jørgensen, Christian Fynbo Christiansen, Victor J. Verwaal, Rikke Hagemann‐Madsen, Lene Hjerrild Iversen
Abstract
The overall risk of M-PM in patients with colorectal cancer is low, but is increased in advanced T and N status. Follow-up of at least 3 years after colorectal cancer surgery may be necessary, given the potential curative treatment of early diagnosed M-PM.
Related Papers
- → APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis(2011)132 cited
- → Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata(2012)23 cited
- → Targeted Therapy of Colorectal Cancer Liver Metastasis(2016)
- → New research progress in molecular mechanisms of colorectal liver metastasis(2016)
- → Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study(2020)